VivoSeq
Other

Azithromycin

0

Pipeline Programs↗

10

Active Trials↗

11

Companies Involved↗

Azithromycin is an early-stage landscape with 0 programs across 11 companies. The most active players are Pfizer, Merck & Co., Novartis.

Intelligence

Pipeline Metrics

Competitive Density

27/100

Pipeline Velocity

11/100

Mech. Concentration

N/A

Completion Rate

86/100

Attrition Rate

10/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

Pfizer logo

Pfizer

0 programs

PreclinicalMerck & Co. logo

Merck & Co.

0 programs

PreclinicalNovartis logo

Novartis

0 programs

PreclinicalTeva logo

Teva

0 programs

PreclinicalMylan Pharmaceuticals Inc logo

Mylan Pharmaceuticals Inc

0 programs

PreclinicalGSK logo

GSK

0 programs

Preclinical

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

96

clinical trials

Completed62 · 65%
Unknown status14 · 15%
Recruiting6 · 6%
Terminated6 · 6%
Withdrawn4 · 4%
Active, not recruiting2 · 2%
Other2 · 2%

Clinical Trials

Trial Activity

96 trials

Azithromycin for Meningococcal Carriage
Recruiting·EEmory University·Phase 2·NCT06618534·1,120 enrolled
Optimising Azithromycin Prevention Treatment in COPD to Reduce Exacerbations
Recruiting·DDr Ian B Wilkinson·Phase 4·NCT05772013·1,311 enrolled
Azithromycin for Child Survival in Niger II
Recruiting·UUniversity of California, San Francisco·Phase 4·NCT06358872·3,300,000 enrolled
Azithromycin and Ampicillin for Late PPROM
Recruiting·SSheba Medical Center·Phase 4·NCT07183462·311 enrolled
Erythromycin Versus Azithromycin for Preterm Prelabor Rupture of Membranes
Recruiting·IInova Health Care Services·Phase 3·NCT06273891·140 enrolled
Azithromycin Before Induction
Recruiting·—·Phase 1·NCT06543290·400 enrolled
Single Dose Azithromycin to Prevent Cholera in Children
Active, not recruiting·MMassachusetts General Hospital·Phase 2·NCT04326478·920 enrolled
Improving Care Through Azithromycin Research for Infants in Africa
Active, not recruiting·BBarcelona Institute for Global Health·Phase 3·NCT04235816·20,560 enrolled
Vitality in Infants Via Azithromycin for Neonates Trial
Not yet recruiting·UUniversity of California, San Francisco·Phase 4·NCT05763693·4,000 enrolled
Comparing Efficacy of Tea Tree Oil Versus Topical Azithromycin in Treating Dry Eye
Not yet recruiting·EEhab Mohamed Elsayed Mohamed Saad·Phase 1/2·NCT06921525·44 enrolled
Comparative Bioavailability Study of Azithromycin 200mg/5mL Suspension Following a 600mg Dose Under Fed Conditions
Completed·Novartis logoNovartis·Phase 1·NCT00875966·42 enrolled
A Single and Repeat Dose PK/PD Study to Characterise Biomarker Response in Healthy Subjects Treated With Azithromycin
Completed·GSK logoGSK·Phase 1·NCT01416350·20 enrolled
A Phase 1 Study To Estimate The Relative Bioavailability Of Fixed Combination Tablets Of Azithromycin And Chloroquine Compared To Co-Administered Individual Tablets Of Azithromycin And Chloroquine
Completed·Pfizer logoPfizer·Phase 1·NCT00844207·40 enrolled
A Study of Azithromycin in HIV-Infected Patients
Completed·Pfizer logoPfizer·Phase 1·NCT00002344·12 enrolled
Comparison of Efficacy of Azithromycin and Levamisole Versus of Azithromycin in in the Treatment of Acne
Completed·—·Phase 2/3·NCT01348321·169 enrolled
Page 1 of 7

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)